The kind of clients Markus works with ranges from single inventors to large-scale enterprises. Besides drafting of patent applications and prosecution, Markus offers guidance to his clients in terms of patent portfolio management and litigation strategies.
Markus advises his clients in the field of trademark and design law.
Before starting in a large Munich patent law firm he worked in a patent law firm in New York City.
Markus holds a Bachelor and Master’s degree of Science in molecular Biotechnology at the Technical University in Munich. During his studies Markus worked at the University of Amsterdam and studied one semester at the Nanyang Technological University in Singapore. After three years of research at the Max-Planck Institute for Infectious Biology in Berlin he received his Doctor’s degree in the field of molecular biology, especially (auto) antibodies.
Markus is a Patentanwalt (German Patent Attorney), European Patent Attorney as well as European Trade Mark and Design Attorney.
BSc in Science
MSc in Science
PHD in Immunobiology
January 29th 2020
June 3rd 2019
October 18th 2018
Markus is providing training sessions to German Patent and Trademark Attorney and European Patent Attorney Trainees and also to support staff.
Further, he is a member of the examination board for German patent paralegals (Patentanwaltsfachangestellte).
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
How to streamline the trade mark selection process by conducting effective, in-house ‘dirty searches’. Selecting the right trade mark for your new healthcare product is a critically important task. Consumers …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF is sponsoring WIPR Trademarks Live conference 2021 with Partner Lee Curtis speaking on 8th June. WIPR Trademarks Live is designed to provide critical and timely insights from leading trademark …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.